标题
Hepatitis C: Is eradication possible?
作者
关键词
-
出版物
LIVER INTERNATIONAL
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-11-25
DOI
10.1111/liv.14011
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm
- (2018) Antonio Cuadrado et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease
- (2018) Lisa I. Backus et al. HEPATOLOGY
- Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020
- (2018) Nick Scott et al. JOURNAL OF HEPATOLOGY
- Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe
- (2018) Hannah Fraser et al. JOURNAL OF HEPATOLOGY
- Assessing the cost-effectiveness of hepatitis C screening strategies in France
- (2018) Sylvie Deuffic-Burban et al. JOURNAL OF HEPATOLOGY
- Forecasting Hepatitis C liver disease burden on real life data. Does the hidden iceberg matter to reach the elimination goals?
- (2018) Loreta A. Kondili et al. LIVER INTERNATIONAL
- The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations
- (2018) Kelly Safreed-Harmon et al. SEMINARS IN LIVER DISEASE
- Evaluation of dried blood spot samples for screening of hepatitis C and human immunodeficiency virus in a real-world setting
- (2018) Sonia Vázquez-Morón et al. Scientific Reports
- REtrieval And cure of Chronic Hepatitis C (REACH): results of micro-elimination in the Utrecht province
- (2018) Patricia A.M. Kracht et al. LIVER INTERNATIONAL
- Micro-elimination – A path to global elimination of hepatitis C
- (2017) Jeffrey V. Lazarus et al. JOURNAL OF HEPATOLOGY
- What is the impact of treatment for hepatitis C virus infection?
- (2017) Stefan Z Wiktor et al. LANCET
- Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program
- (2017) Martin Kåberg et al. Infectious Diseases
- Barriers to Successful Linkage to Care Among HCV Positive Individuals Presenting to a Major Tertiary Medical Center on Long Island, New York
- (2017) Audun Lier et al. Open Forum Infectious Diseases
- Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
- (2017) Rakesh Aggarwal et al. PLoS One
- Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis
- (2016) Bryony Simmons et al. CLINICAL INFECTIOUS DISEASES
- HCV epidemiology in high-risk groups and the risk of reinfection
- (2016) Håvard Midgard et al. JOURNAL OF HEPATOLOGY
- Who to test and how to test for chronic hepatitis C infection – 2016 WHO testing guidance for low- and middle-income countries
- (2016) Philippa J. Easterbrook JOURNAL OF HEPATOLOGY
- Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection
- (2016) Prowpanga Udompap et al. JOURNAL OF HEPATOLOGY
- The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
- (2016) Jack Stone et al. PLoS One
- Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus
- (2015) Nikolien van de Ven et al. HEPATOLOGY
- Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activity
- (2015) Alla Kachko et al. HEPATOLOGY
- Reducing the neglected burden of viral hepatitis in Africa: Strategies for a global approach
- (2015) Maud Lemoine et al. JOURNAL OF HEPATOLOGY
- Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring
- (2015) Alexandre Soulier et al. JOURNAL OF INFECTIOUS DISEASES
- Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage
- (2015) Julie Bottero et al. Open Forum Infectious Diseases
- Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago
- (2015) Desarae Echevarria et al. PLoS One
- Can hepatitis C be eradicated in the United States?
- (2014) Brian R. Edlin et al. ANTIVIRAL RESEARCH
- Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States, 2006–2012
- (2014) Anil G. Suryaprasad et al. CLINICAL INFECTIOUS DISEASES
- Signatures of Protective Memory Immune Responses During Hepatitis C Virus Reinfection
- (2014) Mohamed S. Abdel-Hakeem et al. GASTROENTEROLOGY
- A prophylactic hepatitis C virus vaccine: A distant peak still worth climbing
- (2014) Thomas F. Baumert et al. JOURNAL OF HEPATOLOGY
- HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact
- (2014) N. K. Martin et al. JOURNAL OF VIRAL HEPATITIS
- Polio in Syria
- (2014) R Bruce Aylward et al. LANCET
- After 2015: infectious diseases in a new era of health and development
- (2014) C. Dye PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis
- (2014) Baligh R. Yehia et al. PLoS One
- A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
- (2014) L. Swadling et al. Science Translational Medicine
- Relationship Between Hepatitis C Clinical Testing Site and Linkage to Care
- (2014) S. A. Assoumou et al. Open Forum Infectious Diseases
- Evaluation of a new rapid test kit to detect hepatitis C virus infection
- (2013) Myeong Hee Kim et al. JOURNAL OF VIROLOGICAL METHODS
- Disease Eradication
- (2013) Donald R. Hopkins NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis C Testing, Infection, and Linkage to Care Among Racial and Ethnic Minorities in the United States, 2009–2010
- (2012) Rania A. Tohme et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Chronic hepatitis C virus (HCV) disease burden and cost in the United States
- (2012) Homie Razavi et al. HEPATOLOGY
- Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia
- (2012) Margaret E Hellard et al. MEDICAL JOURNAL OF AUSTRALIA
- Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
- (2012) E. Barnes et al. Science Translational Medicine
- Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008
- (2011) Maxine M. Denniston et al. HEPATOLOGY
- Mathematical modelling of hepatitis C treatment for injecting drug users
- (2011) Natasha K. Martin et al. JOURNAL OF THEORETICAL BIOLOGY
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX™ vaccine: A phase I study in healthy volunteers
- (2010) Debbie Drane et al. Human vaccines & immunotherapeutics
- Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility
- (2010) Natasha K. Martin et al. JOURNAL OF HEPATOLOGY
- Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
- (2010) Sharon E. Frey et al. VACCINE
- Murine neutralizing antibody response and toxicity to synthetic peptides derived from E1 and E2 proteins of hepatitis C virus
- (2009) Mostafa K. El-Awady et al. VACCINE
- Cost-effectiveness analysis of a hypothetical hepatitis C vaccine compared to antiviral therapy
- (2008) E. MASSAD et al. EPIDEMIOLOGY AND INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started